EFPIA Member Survey on Current Inspection Trends
Recommendation
21-23 May 2025
Copenhagen, Denmark
Initial and Continuous Professional Training for GMP Auditors
Register now for ECA's GMP Newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has been conducting member surveys on inspections since 2003. These are intended to provide an up-to-date overview of the type and scope of GMP inspections carried out at the production sites of member companies. The surveys now also include GDP inspection and ISO certifications. Now the EFPIA has published the "Annual Regulatory GMP/GDP Inspection Survey 2021 Data". Especially with regard to the pandemic, this contains interesting data.
For example, the number of inspections at production sites in 2021 was similar to the number before the pandemic. The trends also triggered by the pandemic continue. Thus, the number of domestic inspections is rising again, while foreign inspections are still low. All types of inspections were carried out (PAI, routine, for cause, etc.) and different inspection tools were used (from purely virtual, to combinations, to completely on-site).
The data suggests that virtual tools such as remote assessments and on-site inspections require a similar inspection duration. However, little consideration was given to the actual time required for preparation on both sides.
But see for yourself: Annual Regulatory GMP/GDP Inspection Survey 2021 Data
Related GMP News
04.12.2024Discarded Batch Documentation again found during Inspection
30.10.2024From missing Analysis to Brand Protection Violations - FDA Warning Letter to Canadian Manufacturer
23.10.2024Root Cause Analysis: What can be found in FDA Warning Letters?
23.10.2024Do you want to host FDA Staff? FDA announces Experiential Learning Site Visit Program
09.10.2024Management circumvents Quality Department in Deviation Classification - FDA Warning Letter
09.10.2024Despite MRA: Why does the FDA inspect so frequently in the EU?